三博脑科：拟认购上海德联博健创业投资合伙企业部分份额

Group 1 - The core viewpoint of the article is that Sanbo Brain Science (301293.SZ) aims to enhance its business scale and core competitiveness by investing in a venture capital fund, thereby leveraging capital market advantages and professional investment management [1] - The company plans to subscribe to 87 million yuan worth of shares in the Shanghai Delian Bojian Venture Capital Partnership, which has a total fundraising target of 300 million yuan [1] - The investment is part of a strategy to improve the management of Sanbo Brain Science Hospital Management Group and to elevate the level of medical services [1]